Project Grant R01CA310962
Award Date 7/1/26
Completion Date 6/30/31
Dollars Obligated $712K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
- Federal Grant Award Summary Brigham & Women's Hospital received a $3.16 million Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) awarded on August 14, 2025, with performance through July 31, 2029. The project develops and validates magnetic resonance fingerprinting (MRF) technology to non-invasively image glutamate metabolism in glioblastoma and other brain tumors. The research addresses a critical clinical need by...
- Federal Project Grant Award Summary The National Cancer Institute awarded a Project Grant of $676,849 to the Sloan-Kettering Institute for Cancer Research under the Cancer Treatment Research program (CFDA 93.395) to substantially enhance MIRDSOFT.org, an open-source radiation dosimetry platform. The award, effective July 1, 2026 through June 30, 2031, supports the development of enhanced dosimetry software and computational tools to enable personalized dose estimation in nuclear medicine and...
- Federal Grant Award Summary The National Institute of Environmental Health Sciences awarded a $446,800 Project Grant on September 27, 2025, to Massachusetts General Hospital under the Medical Library Assistance program (CFDA 93.879) to enhance the Open Health Imaging Foundation (OHIF) Viewer and its underlying libraries, including Cornerstone3D. This open-source web-based platform delivers professional-grade imaging informatics capabilities for cancer research and medical imaging applications,...
- Federal Grant Award Summary The National Cancer Institute awarded Sloan-Kettering Institute for Cancer Research a $693,290 Project Grant under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) effective May 1, 2026, through April 30, 2031. This award supports research to identify spatial tumor microenvironment (TME) signatures for risk stratification in primary melanoma. The project will deliver whole-slide multiplex immunofluorescence (MIF) tissue imaging analysis of 450 stage...
- Federal Grant Award Summary The National Cancer Institute awarded Sloan-Kettering Institute for Cancer Research a $644,423 Project Grant under the Cancer Treatment Research program (CFDA 93.395) on June 18, 2026, with a completion date of May 31, 2031. This award supports the development and evaluation of short-wave infrared (SWIR) Cerenkov luminescence imaging (CLI) technology to improve visualization and monitoring of targeted radiotherapy agents and diagnostic radiotracers. The research...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $1.602M Project Grant award from the National Institute of Environmental Health Sciences under the Medical Library Assistance program (CFDA 93.879) effective September 1, 2025, through August 31, 2029. The project focuses on developing computational methods for analyzing multiplex immunofluorescence (MIF) imaging data of the tumor microenvironment. The research leverages a clinically validated MIF dataset encompassing...
- Federal Project Grant Award Summary Brigham & Women's Hospital has received a $819,628 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), effective May 1, 2026 through April 30, 2031. The award funds the AI-CCHASE (AI-Enabled Cancer Chatbots for Symptom Education) initiative, which will develop advanced artificial intelligence-powered chatbot technologies to improve cancer symptom management and patient education. The...
- Federal Project Grant Award Summary The National Cancer Institute awarded Harvard College's Office for Sponsored Programs a $604,102 Project Grant on May 1, 2026, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to develop innovative three-dimensional (3D) bioprinted vascular cancer models for immunotherapy research. Over the five-year project period (through April 30, 2031), the research will deliver preclinical models that enable study of T cell trafficking,...
- Federal Grant Award Summary The National Cancer Institute awarded a $833,467 Project Grant to Dana-Farber Cancer Institute (DFCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for the development and deployment of ACTIVATE (AI-Driven Clinical Trial Information and Viability Assessment Tool for EHRs). The award, effective September 17, 2025 through August 31, 2030, aims to develop open-source artificial intelligence tools to improve cancer clinical trial feasibility...
- Federal Grant Award Summary The National Cancer Institute awarded a $371,161 Project Grant to the University of Colorado-Denver under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) on September 1, 2025, for a two-year performance period concluding August 31, 2027. The award funds the development of artificial intelligence (AI) algorithms designed to improve cervical cancer screening in low-resource settings. Specifically, the project will create advanced AI risk stratification...